Baker McKenzie advised shareholders of Biopharma
The Kyiv office of Baker McKenzie advised the shareholders of Biopharma, a leading Ukrainian manufacturer of pharmaceuticals and healthcare products, on the carve-out of its non-plasma business and its further sale to Stada AG, a global manufacturer of pharmaceuticals and consumer healthcare products.
The Baker McKenzie team was co-led by Kyiv office partners Viacheslav Yakymchuk, head of the Corporate M&A practice group, and Olha Demianiuk, head of the Healthcare & Life Sciences industry group, with key input from associates Andrii Finogin, Olha Sviatenka and Khrystyna Penyk , and London-based senior corporate associate Robert Gray. The team also included antitrust and competition partner Oksana Simonova and senior associate Olha Mikheieva.
